: ¸¶ÀÌŸÄÉ D-Fraction ĸ½¶ 120 ct MW  

»óÇ°À̸§ : ¸¶ÀÌŸÄÉ D-Fraction ĸ½¶ 120 ct MW  
»ç¿ë¿ëµµ : Ç×¾Ï ¹× °¨±â ¸é¿ª·Â ÁõÁø
Æ÷Àå¿ë·®: 120 ĸ½¶
Á¦Á¶È¸»ç : MUSHROOM WISDOM
½ÃÁß°¡°Ý : 79,000¿ø
ÆǸŰ¡°Ý : 40,300¿ø
  Áֿ伺ºÐ : ¸¶ÀÌ´ÙÄÉ ¹ö¼¸ ºÐ¸» 300 mg ¿Ü ÃßÃâ¹° µî
  ÀÌ¿ë¹æ¹ý : 1ÀÏ 2ȸ, 1ȸ 2 ĸ½¶, °øº¹¿¡ µå¼¼¿ä
  ÁÖÀÇ»çÇ× :
 
 
  Á¦Ç°¼³¸í :
 
 





¸¶ÀÌŸÄÉ D-Fraction ( MAITAKE)



´ëÇ¥¼ººÐ : ¸¶ÀÌ´ÙÄÉ ¹ö¼¸ ºÐ¸» 300 mg ¿Ü ÃßÃâ¹° µî


Æ÷Àå¿ë·® : 120 ĸ½¶


¸¶ÀÌŸÄÉ(Maitake)¹ö¼¸Àº ( Çѱ¹¸í: ÀÙ»õ¹ö¼¸)
¿¡µµ(Ë°ûÂ)½Ã´ë¿¡´Â ¸¶ÀÌŸÄÉ ¸¦ Àº°ú ¹Ù²Ù¾î ÁÙ¸¸Å­ ±ÍÇÑ ¹ö¼¸À̾ú´Ù°í Çϸç,
ÀÎüÀÇ ¸é¿ª·ÂÀ» ³ô¿©ÁÖ´Â ÇٽɼººÐÀÎ
º£Å¸1,3 ±Û·çÄ­ °ú º£Å¸1,6 ±Û·çÄ­ ÇÔÀ¯

¸¶ÀÌŸÄÉ D-fraction Àº º£Å¸±Û·çÄ­ ¹× Protein À» ¼ø¼öÇÏ°Ô ÃßÃâÇÏ¿©
À¯¿ë¼ºÀ» ³ôÀÎ ¹°Áú·Î ¹Ì±¹ Mushroom Wisdom »çÀÇ µî·Ï»óÇ¥ ÀÔ´Ï´Ù.



Memorial Sloan-Kettering Now Engaged in Clinical Trial On Breast Cancer Patients using Maitake Extract In a government-funded cancer research, Memorial Sloan-Kettering Cancer Center (MSKCC) in New York City has announced in its website that a phase I/II clinical study of Maitake extract is now underway against women who had stage I, II or III breast cancer that was surgically removed. The study is being conducted at MSKCC in collaboration with The New York Presbyterian Hospital-Weill Medical College of Cornell University, to determine if Maitake extract can stimulate the immune system without causing any side effects or toxicity

2005.01.20

.
Maitake D-Fraction¢ç Appears in American Cancer Societyís Guide to Complementary and Alternative Cancer Methods
In response to rising interest among American public in complementary and alternative methods for treating cancer, the American Cancer Society has published two guidebooks to such treatments, both including a section on Maitake D-Fraction¢ç. Maitake D-Fraction¢ç is the flagship product of Maitake Products, Inc. and has been on the dietary supplement market since 1995.


 
 

°Ç°­ÇÑ »î, Áñ°Å¿î »ýÈ° | ¹Ì±¹¼ÒÀç °Ç°­Àü¹® ¼îÇθô- Á¶¾Æ¶óÀÌÇÁ

COPYRIGHT joalife, INC ALL RIGHT RESERVED MAIL: .